2 July 2010 – The U.S. House of Representatives has passed a measure banning patent settlements struck between brand-name and generic pharmaceutical companies to delay the release of generic drugs.  The goal?  To shave nearly $2 billion off government spending over the next decade.  The measure was tacked onto the Iraq and Afghanistan war funding bill. 

The measure aims to the Federal Trade Commisssion (FTC) authority to initiate proceedings against any party that enters into a…

 
 
 

Admin